CD44 promotes angiogenesis in myocardial infarction through regulating plasma exosome uptake and further enhancing FGFR2 signaling transduction
Abstract Background Since angiogenesis occurs as the pathological process following myocardial infarction to alleviate ischemia, therapeutic angiogenesis has been proposed to be a cardioprotective strategy. CD44 has been implicated in endothelial cell functions and its role has been well established...
Saved in:
Main Authors: | Qing Zhang (Author), Li Chen (Author), Liyi Huang (Author), Hongxin Cheng (Author), Lu Wang (Author), Lin Xu (Author), Danrong Hu (Author), Chengqi He (Author), Chenying Fu (Author), Quan Wei (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2022-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
MicroRNA-132, Delivered by Mesenchymal Stem Cell-Derived Exosomes, Promote Angiogenesis in Myocardial Infarction
by: Teng Ma, et al.
Published: (2018) -
Lenvatinib Suppresses Angiogenesis through the Inhibition of both the VEGFR and FGFR Signaling Pathways
by: Kenji Ichikawa, et al.
Published: (2016) -
CD44-Targeted Carriers: The Role of Molecular Weight of Hyaluronic Acid in the Uptake of Hyaluronic Acid-Based Nanoparticles
by: Enrica Chiesa, et al.
Published: (2022) -
Understanding Hyaluronan Receptor (CD44) Interaction, HA-CD44 Activated Potential Targets in Cancer Therapeutics
by: Gul-, et al.
Published: (2021) -
Modification of Cardiac Progenitor Cell-Derived Exosomes by miR-322 Provides Protection against Myocardial Infarction through Nox2-Dependent Angiogenesis
by: Seock-Won Youn, et al.
Published: (2019)